1.84k likes | 2.09k Views
IMMUNITY. THE ABILITY TO RESIST DISEASE. NONSPECIFIC VS SPECIFIC. http://www.microbiologytext.com/ http://www.gsbs.utmb.edu/microbook/toc.htm. NONSPECIFIC. PHYSICAL BARRIERS CHEMICAL BARRIERS CELLULAR BARRIERS INFLAMMATION FEVER. SPECIFIC IMMUNITY.
E N D
IMMUNITY THE ABILITY TO RESIST DISEASE
NONSPECIFIC VS SPECIFIC http://www.microbiologytext.com/ http://www.gsbs.utmb.edu/microbook/toc.htm
NONSPECIFIC • PHYSICAL BARRIERS • CHEMICAL BARRIERS • CELLULAR BARRIERS • INFLAMMATION • FEVER
SPECIFIC IMMUNITY • IMMUNE CELLS RECOGNIZE FOREIGN ANTIGENS • DIRECTLY OR INDIRECTLY ELIMINATE THEM
ACQUIRED IMMUNITY NATURAL VS ARTIFICIAL ACTIVE VS PASSIVE
NATURALLY ACQUIRED ACTIVE IMMUNITY • DUE TO ANTIGENIC STIMULUS FROM INFECTION • ANTIBODIES • SENSITIZED LYMPHOCYTES • SHORT TERM TO LONG TERM • MEMORY CELLS MADE
NATURALLY ACQUIRED PASSIVE IMMUNITY • ANTIBODIES TRANSFERRED FROM MOTHER TO INFANT • ACROSS THE PLACENTA • Ig G • SHORT TERM IMMUNITY • IN THE CLOSTRUM AND MILK • IgA • AS LONG AS BABY IS NURSING • NO MEMORY CELLS ARE FORMED
ARTIFICIALLY ACQUIRED ACTIVE IMMUNITY • VACCINATIONS/IMMUNIZATION • KILLED OR WEAKENED MICROBES • INACTIVATED TOXINS • COMPONENTS OF CAPSIDS, CAPSULES OR OTHER MICROBIAL COMPONENTS • VECTOR VACCINES • MEMORY CELLS ARE FORMED
ARTIFICIALLY ACQUIRED PASSIVE IMMUNITY • TRANSFER OF ANTIBODIES FROM SOME OTHER ORGANISM • SHORT TERM IMMUNITY • NO MEMORY CELLS FORMED
ANTIGENS • ANTIBODY GENERATING MOLECULES • IMMUNOGENS/ALLERGENS • SELF VS NONSELF • MARKERS ON CELLS, PROTEINS, VIRUSES AND ETC
CHARACTERISTICS OF ANTIGENS • LARGE • COMPLEX • PROTEINS • NUCLEOPROTEINS • POLYSACCHARIDES • GLYCOLIPIDS
ANTIGENIC DETERMINANT SITES • SITES ON ANTIGEN THAT CAUSE PRODUCTION OF ANTIBODY • MONOVALENT • MULTIVALENT • HETEROPHILE OR HETEROLOGOUS
HAPTENS • SMALL ORGANIC MOLECULES • NOT ANTIGENIC BY ITSELF • MUST BIND TO CARRIER MOLECULE • PENICILLIN • NICKEL
CELLS OF THE SPECIFIC IMMUNE RESPONSE LYMPHOCYTES
LYMPHOCYTE FUNCTION B CELL
B CELLS • MADE IMMUNOCOMPETENT IN FETAL LIVER AND BONE MARROW
PLASMA CELLS • DERIVED FROM B CELLS • RESPOND TO ANTIGEN BY SECRETING ANTIBODIES • HUMORAL DEFENSE • DEFEND AGAINST BACTERIA, BACTERIAL TOXINS AND VIRUSES FOUND IN BODY TISSUES
ANTIBODIES • GLYCOPROTEINS • GAMMA GLOBULIN PORTION OF SERUM • DIFFER IN MOLECULAR SIZE, STRUCTURE, CHARGE, AMINO ACID COMPOSITION AND CARBOHYDRATE COMPOSITION • FIVE CLASSES
IMMUNOGLOBULINS • IgA • IgD • IgE • IgG • IgM
CHARACTERISTICS OF ANTIBODIES • MOST ARE BIVALENT • CRYSTALIZABLE FRAGMENT (Fc) • ANTIBODY BINDING FRAGMENT (Fab) • FOUR POLYPEPTIDE BONDS • LIGHT AND HEAVY CHAINS • HEAVY CHAINS DETERMINE CLASS • FLEXIBLE HINGE REGION
ANTIBODY SUBCLASSES • Ig A • Ig G
FUNCTION OF IMMUNOGLOBULINS • ALL ARE BIFUNCTIONAL • Fab BINDS TO ANTIGEN • Fc BINDS TO COMPLENT AND CELLS • DOES NOT LEAD TO DIRECT DESTRUCTION • MARKS CELL FOR DESTRUCTION • ACTIVATES NONSPECIFIC RESPONSES
IMMUNOGLOBULIN G • MAJOR Ig IN SERUM • 70-75 % OF IMMUNOGLOBULIN POOL • ACTS AGAINST BACTERIA AND VIRUSES • OPSONIZING AND NEUTRALIZING • ACTIVATES COMPLEMENT • CROSSES PLACENTA
SUBCLASSES OF IgG • Ig1 • Ig2 • Ig3 • Ig4 • VARY IN COMPOSITION AND NUMBER AND ARRANGEMENT OF DISULFIDE BONDS
IMMUNOGLOBULIN M • ABOUT 10 % OF IMMUNOGLOBULIN POOL • FOUND ONLY IN SERUM • MONOMERS, PENTAMERS, HEXAMERS • JOINING CHAINS • FIRST ANTIBODY PRODUCED • FOUND ON B CELL MEMBRANES
FUNCTION OF IgM • FIRST ANTIBODY PRODUCED IN PRIMARY IMMUNE RESPONSE • AGGLUTINATES • ACTIVATES COMPLEMENT • BY CLASSICAL PATHWAY • OPSONIZES • MONOMERIC FORMS ARE FOUND ON SURFACE OF B LYMPHOCYTES • ACT AS RECEPTORS FOR ANTIGEN
IMMUNOGLOBULIN A • 15 % OF POOL • MAINLY DIMER IN SERUM
SECRETORY IgA • SECRETORY IMMUNE SYSTEM • SPECIAL SECRETORY COMPONENT • GI TRACT • RESPIRATORY TRACTS • GENITOURINARY TRACT • SALIVA • TEARS • SWEAT
FUNCTION OF IgA • PROTECTS BODY SURFACES • IMMUNE EXCLUSION • BINDS TO TO ANTIGENS IN LAMINA PROPRIA • ACTIVATES COMPLEMENT BY ALTERNATIVE PATHWAY
IMMUNOGLOBULIN D • TRACE AMOUNTS IN SERUM • MAINLY FOUND ON B CELLS • REGULATES IMMUNE SYSTEM • MONOMER • MAY PLAY ROLE IN ELIMINATING SELF-REACTIVE AUTOANTIBODIES
IMMUNOGLOBULIN E • LESS THAN 1% OF ANTIBODY • SKIN SENSITIZING • ANAPHYLACTIC • BINDS TO MAST CELLS AND BASOPHILS • FIGHTS PARASITES
ANTIBODY DIVERSITY • REARRANGEMENT OF EXONS • SOMATIC MUTATIONS • POST TRANSCRIPTIONAL EDITING • INDEPENDENT ASSORTMENT OF LIGHT AND HEAVY CHAINS
ANTIBODY SPECIFICITY • INFINITE NUMBER OF ANTIBODIES POSSIBLE • BASED ON B CELL CLONES
CLONAL SELECTION THEORY • SMALL SET OF CELLS THAT CAN RESPOND TO ANTIGEN • ALL ARE PRESENT IN FETUS • ANTIGEN SELECTS THE APPROPRIATE CLONE • EFFECTOR AND MEMORY CELLS ARE PRODUCED
PRIMARY ANTIBODY RESPONSE • INITIAL CHALLENGE • LAG PHASE • LOG PHASE • PLATEAU • PASTEUR PHASE • LOW ANTIBODY AFFINITY
SECONDARY IMMUNE RESPONSE • ANAMNESTIC RESPONSE • PROVIDES IMMUNITY • CLONES OF B OR T MEMORY CELLS • SHORTER LOG PHASE • HIGH ANTIBODY AFFINITY
POLYCLONAL VS MONOCLONAL ANTIBODIES http://users.rcn.com/jkimball.ma.ultranet/BiologyPages/M/Monoclonals.html
CHIMERIC MONOCLONAL ANTIBODIES • PART HUMAN --- PART MOUSE • VARIABLE REGION—MOUSE • CONSTANT REGION HUMAN • 66% HUMAN • LESS TOXIC
HUMANIZED ANTIBODIES • THE ANTIGEN BINDING SITE IS THE ONLY PORTION OF THE ANTIBODY THAT CONTAINS MOUSE PROTEINS • 90% IS HUMAN
FULLY HUMAN ANTIBODIES • TRANSGENIC MICE • GENETICALLY MODIFIED MICE CONTAIN HUMAN ANTIBODY GENES • WOULD PRODUCE FULLY HUMAN ANTIBODIES • MIGHT BE POSSIBLE TO PRODUCE THEM TO MATCH THE SPECIFIC PATIENT
CATALYTIC ANTIBODIES • USED TO TRANSFORM SIMPLE COMPOUNDS • BLOOD CLOTS INHEART
ACTIVATION OF COMPLEMENT TOXIN NEUTRALIZATION VIRAL NEUTRALIZATION AHERANCE INHIBITION PARASITIC INFECTIONS ANTIBODY DEPENDENT CELL MEDIATED CYTOTOXITY OPSONIZATION REGULATING INFLAMMATION IMMUNE COMPLEX ANTIBODY FUNCTION
FUNCTION OF COMPLEMENT • MEDIATE INFLAMMATION • CHEMOTAXIS • PHAGOCYTE ACTIVATION • CYTOLYSIS • OPZONIZATION • ACTIVATION OF OTHER IMMUNE CELLS
COMPLEMENT ACTIVATION • COMPLEMENT MAKES UP A MAJOR PORTION OF SERUM